drugset / Trial / NCT02936830

Effectiveness of Nanohydroxyapetite Paste on Reducing Dentin Hypersensitivity

NCT02936830

Phase 4 Completed 63 enrolled Riyadh Colleges of Dentistry and Pharmacy
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to compare the efficacy of dentine hypersensitivity reduction using in office paste formula containing nanoHydroxyapatite with the commercially available fluoride (duraphat) and a placebo in treating hypersensitivity in a single visit.

Timeline

Start
2016-10
Primary completion
2017-03
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nanohydroxyapetite Unknown 15 % Topical
Comparator sodium fluoride Unknown 5 % Topical

Indications